Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Anti-CD19-CD20 CAR T cells|
Anti-CD19-CD20 CAR T-cells are T-cells that are engineered to express a bispecific antibody that targets CD19 and CD20, which potentially results in an anti-tumor immune response against cells expressing either CD19 or CD20 (PMID: 27059623, PMID: 29207878).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Anti-CD19-CD20 CAR T cells||Anti-CD19-CD20 CAR T cells||0||2|
|Anti-CD19-CD20 CAR T cells + Cyclophosphamide + Fludarabine||Anti-CD19-CD20 CAR T cells Cyclophosphamide Fludarabine||0||1|